AADI BIOSCIENCE INC (AADI) Stock News

USA - Nasdaq - NASDAQ:AADI - US00032Q1040 - Common Stock

2.05 USD

-0.05 (-2.38%)

Last: 3/18/2025, 8:20:08 PM

2.06 USD

+0.01 (+0.49%)

After Hours: 3/18/2025, 8:20:08 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

AADI Latest News, Press Relases and Analysis

All

Press Releases

9 months ago - By: Aadi Bioscience

Aadi Bioscience to Report Fourth Quarter and Full-Year 2024 Results and Corporate Update

9 months ago - By: Aadi Bioscience

Aadi Bioscience Announces Closing of $100 Million PIPE Financing

10 months ago - By: Aadi Bioscience

Aadi Bioscience Announces Approval of All Proposals at Special Meeting of Stockholders

10 months ago - By: Aadi Bioscience

Aadi Bioscience to Present at the TD Cowen 45th Annual Healthcare Conference

10 months ago - By: Aadi Bioscience

Aadi Bioscience Filed Definitive Proxy Statement and Schedules Special Meeting of Stockholders for February 28, 2025

a year ago - By: Benzinga

Why Is Cancer-Focused Aadi Bioscience Stock Trading Higher On Friday?

2 years ago - By: Benzinga

Aadi Bioscience Earnings Preview

a year ago - By: Aadi Bioscience

Aadi Bioscience Transforms with In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO® and $100 Million PIPE Financing

a year ago - By: Aadi Bioscience

Aadi Bioscience Announces Financial Results for the Third Quarter 2024 and Provides Corporate Update

a year ago - By: Aadi Bioscience

Aadi Bioscience to Report Third Quarter 2024 Results and Corporate Update

a year ago - By: Aadi Bioscience

Aadi Bioscience Provides PRECISION1 Trial and Corporate Updates

a year ago - By: Aadi Bioscience

Aadi Bioscience Announces Financial Results for the Second Quarter 2024 and Provides Corporate Update

a year ago - By: Aadi Bioscience

Aadi Bioscience to Report Second Quarter 2024 Results and Corporate Update

a year ago - By: BusinessInsider

3 Russell 2000 Stocks to Sell in July Before They Crash & Burn

a year ago - By: InvestorPlace - Mentions: AAOI BCAL

3 Russell 2000 Stocks to Sell in July Before They Crash & Burn

2 years ago - By: Aadi Bioscience

Aadi Bioscience to Participate in the Jefferies Healthcare Conference

2 years ago - By: Aadi Bioscience

Aadi Bioscience Presents New Nonclinical Data Demonstrating Preferential Tumor Uptake of nab-Sirolimus at the American Society of Clinical Oncology (ASCO) Annual Meeting

2 years ago - By: InvestorPlace

AADI Stock Earnings: Aadi Bioscience Misses EPS, Misses Revenue for Q1 2024

2 years ago - By: Aadi Bioscience

Aadi Bioscience Announces Financial Results for the First Quarter 2024 and Provides Corporate Update

2 years ago - By: Aadi Bioscience

Aadi Bioscience to Report First Quarter 2024 Results and Corporate Update

2 years ago - By: Aadi Bioscience

Aadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with nab-Sirolimus at Society of Gynecologic Oncology (SGO)

2 years ago - By: Aadi Bioscience

Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Corporate Update

2 years ago - By: Aadi Bioscience

Aadi Bioscience to Report Fourth Quarter and Full-Year 2023 Results and Corporate Update

2 years ago - By: Aadi Bioscience

Aadi Bioscience to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024

2 years ago - By: Aadi Bioscience

Aadi Bioscience Announces Publication of Long-Term Efficacy and Safety Data Further Supporting FYARRO® for the Treatment of Malignant PEComa

2 years ago - By: Aadi Bioscience

Aadi Bioscience to Present at the TD Cowen 44th Annual Healthcare Conference

2 years ago - By: Seeking Alpha

Aadi Bioscience files for $150M mixed shelf (NASDAQ:AADI)

2 years ago - By: Aadi Bioscience

Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium

2 years ago - By: Aadi Bioscience

Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium